• Preliminary experiments 1 have shown that in the isolated heart of the guinea pig, bradykinin produces a considerable increase in coronary flow at concentrations comparable to those which are active on the isolated rat's uterus or rat's duodenum, so far the most sensitive preparations for the biological assay of bradykinin. In the present report, the vasodilating effect of bradykinin on the coronary vessels in the isolated heart is further investigated, and other species of animals are utilized in the experiments.
Methods

LANOENDORFF'S PREPARATION
The animals were sacrificed with a blow on the head, exsanguinated by cutting the vessels of the neck, the thorax immediately opened, and a cannula inserted into the aorta. The heart was dissected from its connections with the thoracic organs and the perfusion with a modified Ringer-Locke solution (9.0 Gm. NaCl; 0.42 Gm. KCl; 0.24 Gm. CaCl 2 ; 0.15 Gm. NaHCO 3 ; 0.01 Gm. NaH 2 P0 4 ; 1 Gm. glucose per L.) started immediately. The use of heparin or refrigeration prior to the washing with the perfusion fluid was considered unnecessary, except for the rat in which heparin was injected before sacrifice.
The total fluid passing through the heart via the aorta was collected, and the flow was measured with a drop counter (Gaddum, 1938) 2 or an outflow recorder (Andrews, 1952) 3 in connection with a piston recorder (C. F. Palmer, Ltd.). Calibration of the apparatus was done in the usual way by flowing saline from a burette for certain intervals of time.
The perfusion fluid was kept at 36 C, and a pressure of 45 to 50 mm. Hg was maintained under constant oxygenatdon. The injections were given through a rubber capsule at a distance of 2 to 3 em. from the connections of the cannula with the aorta. The final dilution would be about one-tenth to one-twentieth of the original solution. The solutions were made tip in saline, and the volumes injected varied from 0.1 to 0.25 ml.
In a few experiments, a polyethylene tube was also inserted into the pulmonary artery and the flow registered separately from the 'leakage fluid." As indicated by others,* this leakage fluid as a rule is a small part (15 to 20 per cent) of the total passing through the heart. This was confirmed in our experiments, the leakage volume being about IS per cent of the total. When bradykinin was injected in these control experiments, the "pulmonary flow" was raised as usual, but the "leakage fluid" did not change significantly. From these experiments, it appears safe to conclude that the increase in flow observed after the injection of bradykinin was almost exclusively due to a dilatation of the coronary bed.
The heart beats were registered by means of an isotonic lever. In some experiments, the drum was accelerated at the peak of the effect in order to have a pictorial representation of the mechanical changes induced by the drug. In most cases, however, the beats were counted directly.
Synthetic bradykinin (SBR 640, Sandoz, Ltd.) was used in most experiments. Only occasionally, our standard bradykinin was utilized for comparison. In other structures, the ratio of activity was one unit standard bradykinin = 0.5 /xg. SBR of synthetic bradykinin. 6 Epinephrine (Parke-Davis), norepinephrine (Byk), oxytocin (Sandoz, Ltd., "Syntocynon"), papaverin,e (Houdfi), and histamine (diphosphate, Abbott) were commercial brands utilized routinely in our laboratory.
Results
GUINEA PIGS
The isolated heart of the guinea pig was by far the most sensitive to the vasodilating effect of bradykinin. Doses of the order of 0.001 to 0.005 fig. (final solutions 10" 10 to 10" 0 ) were already active on the coronary flow in most preparations, producing only slight or no effect on the amplitude of the beat or slight acceleration of the rhythm. This contrasted with the effects produced by epinephrine, which was very active on the dynamics of the As shown in table 1, when the effects of bradykinin were compared with those produced by epinephrine, for a similar increase in frequency, the effects of bradykinin on the coronary bed were much greater than those of epinephrine. The doses of epinephrine were already enough to produce an increase of the amplitude of the beats comparable to that produced by bradykinin.
In the tracings of figure 1 , the effects of 0.2 /j.g. of synthetic bradykinin on the coronary flow (number of drops per minute), the frequency and the amplitude of the beats are presented with two velocities of the drum. Although the effects on the flow were very conspicuous, possibly maximal, the increases in amplitude and rate were slight, not exceeding 18 per cent of the normal values. Figure  2 is a continuation of figure 1, giving a picture of the dose/response ratio, with decreasing doses of synthetic bradykinin. Part of the second panel of figure 2 gives the registration of the beats with a velocity of the drum 60 times that of the preceding tracings. Figure 3 was obtained with an Andrews outflow device combined with a piston re- corder. The increase in flow, after 0.02 ^.g. of synthetic bradykinin, was of the order of 300 per cent within 30 seconds after the injection of bradykinin. The increases in amplitude of the beat, as seen in this preparation, were also larger than those usually obtained. This might be due to the fact that tlie amplitudes were low to start with. When bradykinin was added to the perfusing fluid to make a concentration of 0.005 /ug./ml., the increase in flow persisted for a long time, decreasing slowly after reaching a peak of 300 per cent of the control values. The beat amplitude also increased considerably during the infusion. The decrease of coronary flow during a long-lasting perfusion of the coronary bed with many dilators is a trivial finding (Setnikar et al., 1961) ,° indicating possibly some adaptation of the biological structure to a continuous contact with the active material. As far as the beat amplitude is concerned, the effect seen in figure 3 is more marked than the usual effect seen in a strongly beating heart but is out of proportion with what is obtained with doses of epinephrine, producing comparable effects on the coronary flow. This contrast with the effects produced by epinephrine oa the coronary flow and the amplitude of beat is well illustrated in figure 4 where 0.1 fxg. of synthetic bradykinin is compared with 0.2 fxg. of epinephrine. The effects are just the opposite. For a considerable increase of flow produced by bradykinin, with small effect on the amplitude of the beats, epinephrine produced much smaller increases in flow with much larger effects on the amplitude.
When combined with other materials, such as histamine and angiotensin amide, the immediate and powerful dilating effect of bradykinin predominated in all cases. Histamine, for instance, always produces reduction of flow in the isolated guinea pig heart, and increase in frequency and amplitude of the beats. 4 -7 " 10 When 1 fig. of histamine was injected with 0.1 jug. of bradykinin, the increase in flow produced by bradykinin would predominate, and the increase in frequency and amplitude due mainly to histamine persisted or was accentuated.
When bradykinin and epinephrine were combined, the immediate coronary vasodilatation produced by bradykinin predominated. jxg. of bradykinin, there was a small increase in flow. However, larger doses produced considerable increase in flow, with practically no alteration in the rhythm of the heart. Figure  5 shows a comparison between the standard bradykinin (0.2 unit) and 1.0 /xg. of synthetic bradykinin. In some preparations, there was no response of the rabbit's heart to increasing doses of bradykinin, a fact never observed with guinea pig's heart. One explanation for this relative insensitivity of the rabbit's heart might be the fact that the flow in the control periods is usually very high, indicating a permanent loss of tonus of the coronary bed in the rabbit. Therefore, only a few experiments were done in this species.
CATS
The sensitivity of the cat heart to the coronary vasodilating effects produced by bradykinin was midway between the guinea pig and the rabbit. The effects of doses below the ;ug. level were constant and in most preparations produced considerable increase in flow. The changes in rate and amplitude produced by such doses of bradykinin were trivial or unimportant. With higher doses (3 fig. to 5 fig.) , when a considerable increase in coronary flow was observed, there was only a discrete or no effect upon the heart rate and sometimes a decrease in the amplitude of the beat, as shown in figures 6 and 7. However, we could not find any definite correlation between those varying effects on the dynamics of the heart and the persistent increase in coronary flow. Histamine, in the cat, produces a vasodilating effect on the coronary vessels. "Weight by weight, histamine was slightly more potent than bradykinin itself, for flow. Histamine, in doses which produced comparable effects on the flow, affected the rate and amplitude of the contractions more than bradykinin. Epinephrine, on the contrary, although producing a conspicuous increase in coronary flow in the cat, was much more effective in increasing both the rate and the amplitude of the contraction, as seen in figures 6 and 7.
Discussion
Bradykinin, among the known endogenous substances, was found to be one of the most potent coronary vasodilators when assayed on the isolated mammalian heart (guinea pig. rabbit, cat, and dog), with the possible exception of the rat heart, in which, under the conditions of our experiments, bradykinin did not produce any significant change in the coronary flow.
In the guinea pig heart, bradykinin increases the coronary flow in concentrations of the order of 10" 8 to 10~1 0 , being probably the most active endogenous material dilating the coronary vessels in this species. The effect is persistent (no tachyphylaxis), related to the doses applied, and reproducible on a quantitative basis. Consequently, the isolated heart of the guinea pig might constitute a sensitive preparation for the biological assay of bradykinin. Papaverine, when tested on the same preparation, was at least 100 times less active in inducing the same degree of coronary flow. Histamine, as is , well known, reduces the coronary flow of the guinea pig, 4 ' 8 " 10 and epinephrine, although increasing the flow, produces a much more marked effect than bradykinin on the rate and amplitude of the heart in doses which would affect the coronary flow to a lesser extent.
In the cat's isolated heart, histamine produces an effect which is similar to 'that produced by bradykinin, with discrete action on the rate and the amplitude. But here again, epinephrine produces much greater alterations of the rate and amplitude, than in the coronary flow, when compared to both histamine and bradykinin. These effects of histamine and of bradykinin were' not affected by atropine added to theperfusion fluid. -
A few experiments were done in the isolated dog's heart indicating that bradykinin is extremely active in doses of the order of 0.25 /xg. Since our device, in the present circumstances, was set to smaller hearts, we did not bring the study of the effects on the dog's heart to the point of having a clear-cut picture of the phenomenon in this species. But, from a few preliminary experiments, the dog's heart is probably next to the guinea pig's in sensitivity to the vasodilating effect of bradykinin.
Since bradykinin is a potent peripheral vasodilator in all animals studied, including man, its dilating effects on the coronary vessels conform to its pharmacology and are similar to the action of other hypotensive drugs--\vhieh also dilate the coronary bed, such as papaverine, nitrites, aminophylline, etc. The fact that an endogenous principle, which might act as a mediator, has similar actions on the systemic blood pressure and on the coronary bed might be of significance in the interpretation of the pathogenesis of many cardiac affections. The old concept that natural mediators (acetylcholine, catecholamines, and, in certain animal species, histamine) have opposite effects on the systemic and the coronary circulation does not seem to apply to bradykinin.
• Of considerable interest is the question of Circulation Rutareh, Volun* XI, Dtetmbtr lilt whether bradykinin acts directly or by releasing another mediator. From our experiments, we drew the conclusion that the effect of bradykinin is a direct one. In the first place, tachyphylaxis did not occur. Even to threshold doses, the heart responds regularly and in a reproducible way. Among the endogenous principles that might be released, only histamine or catecholamines should be considered. We have seen, however, that in some animal species (guinea pig and rabbit), histamine acts on the coronary bed in the opposite direction. As far as epinephrine is concerned, we have also shown that doses which produce, a similar or smaller coronary dilatation have a much more conspicuous effect on the rate and amplitude of the heart beat, which would exclude the possibility of bradykinin acting through a release of catecholamines, although a small part of this effect might be due to a release of catecholamines, since it has been shown that bradykinin can release catecholamines from the adrenals (Lecomte and Troquet, I960). 11 The opposite, that is, catecholamines dilating the coronary vessels through a release of bradykinin, should be strongly considered inasmuch as the idea that epinephrine dilates the coronary vessels through the intermediary of a metabolite released during the increased functioning of the organ has been suggested (Szentivanyi and Nagy, 1959, and Douglas et al., I960). 12 
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Summary
Synthetic bradykinin (SBR 640) was assayed on the isolated hearts of the guinea pig, the rabbit, the cat, the dog, and the rat. "With the exception of the rat's heart, all reacted strongly to bradykinin with an increase in coronary flow. The guinea pig's heart was by far the most sensitive, reacting to concentrations of bradykinin of the order of 10" 9 to 10~1 0 and therefore being as sensitive as the rat's uterus and rat's duodenum, so far the preparations most sensitive to bradykinin. On the dynamics of a normally beating heart, the effects of bradykinin are slight or trivial. When the amplitude or rate is reduced, Circulation Rettarck, Volumt XI. Dtotmbrr lilt bradykinin tends to increase both. There was, however, no relationship between its effects on the frequency or amplitude and its strong vasodilating effect on the coronary vessels. Since there was no tachyphylaxis to even threshold doses of bradykinin, the conclusion is drawn that it affects directly the coronary bed through its typical vasodilating action.
The possibility of bradykinin being a mediator in the coronary vasodilation produced by epinephrine has been discussed.
